We aspire to transform Lung Cancer from a deadly disease to a managed condition where patients have what matters most: more quality time. We know that a unified approach will get us there, because we are Engineering the extraordinary.

Lung cancer facts

Lung cancer data - Causes

85% of lung cancer cases are caused by smoking.3


Lung cancer data - Diagnosis

74% of lung cancer cases are diagnosed at a late stage.4,5


Lung cancer data - Tobacco use

25% of all cancer deaths globally are linked to tobacco use.3


Lung cancer data - Survival rate

12.6% is the 5 year survival rates for lung cancer.7


  • Lung cancer continues to be a worldwide problem with more people dying of the disease than prostate, breast and colon cancers combined.
  • At present, the majority of new lung cancer cases are recognized at a late stage, which limits treatment options and can significantly reduce the opportunity to improve patient survical.2
  • Lung cancer is the most commonly diagnosed cancer (11.6 % of the total cases) and the leading cause of cancer death (18.4 % of the total cancer deaths).6

 

This has a life-threatening consequence for patients and a potential crisis for health systems.

Innovative and cost-efficient solutions must be found to help diagnose patients quicker, so they can receive earlier the treatment that works best for them.

Medtronic is committed to support earlier detection and treatment of lung cancer to improve its 5 year survival rate and to improve patient outcomes through innovative solutions

 

5 year survival could increase above 70% if lung cancer is detected earlier.8

See a colorful illustration of the lungs.

Achieving earlier diagnosis

Together we can further optimize health outcomes through early diagnosis and early recovery, combining innovative technologies and comprehensive medical education programmes for all healthcare providers involved in patient care.

This is an image of a man and a woman holding hands while sitting down on a dock with their shoes removed and smiling.

Improving survival sates & quality of life

Together we can refine patients' journey through the care continuum enabling them to get deeper understanding and better preparation.

See a group of doctors meeting and taking notes.

Optimizing cost efficiency

Together we can offer solutions that streamline the patient pathway and optimize the care continuum through enhancing partnerships that combine managed services, consultative expertise and innovative technology.

Lung health and thoracic surgery product portfolio

Our goal is always the same: to get patients back to doing what they love — as quickly and safely as possible. We’re committed to innovating technology that optimizes outcomes for patients with lung cancer, esophageal cancer, and other diseases of the chest.

Lung cancer patient resources

Information guide

Download an informational guide to help patients understand the diagnosis, staging, and surgical treatment options for lung cancer.

Rob’s Lung Cancer Journey

Watch Rob’s lung cancer journey from symptoms, surgery to recovery. Learn how advanced medical technology and minimally invasive surgery are transforming patient outcomes.

This is an image of an older woman serving pastries on a plate to a teenage boy and an older man who are sitting on a couch. The image is within a circle on a transparent background.
  1. Lung Cancer Survival Rates | 5-Year Survival Rates for Lung Cancer [Internet]. Cancer.org. 2021 [cited 22 October 2021]. Available from: https://www.cancer.org/cancer/lung-cancer/detection-diagnosis-staging/survival-rates.html
  2. How quickly does lung cancer spread? Your FAQs [Internet]. Medicalnewstoday.com. 2021 [cited 22 October 2021]. Available from: https://www.medicalnewstoday.com/articles/how-fast-lung-cancer-spreads
  3. Tobacco use causes almost one third of cancer deaths in the WHO European Region Feb 2020. https://www.euro.who.int/en/ health-topics/disease-prevention/tobacco/news/news/2020/2/tobacco-use-causes-almost-one-third-of-cancer-deaths-inthe- who-european-region
  4. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8. PMID: 31912902.
  5. Gildea TR, DaCosta Byfield S, Hogarth DK, Wilson DS, Quinn CC. A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. Clinicoecon Outcomes Res. 2017 May 12;9:261-269. doi: 10.2147/CEOR.S132259. PMID: 28553128; PMCID: PMC544003
  6. Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394-424.
  7. Lung cancer - ERS [Internet]. Erswhitebook.org. 2021 [cited 22 October 2021]. Available from: https://www.erswhitebook.org/chapters/lung-cancer/
  8. Blandin Knight Sean, Crosbie Phil A., Balata Haval, Chudziak Jakub, Hussell Tracy and Dive Caroline 2017Progress and prospects of early detection in lung cancerOpen Biol.7170070170070 http://doi.org/10.1098/rsob.170070